Home › Myriad Genetics Upgraded by Credit Suisse to "Neutral"
 

Keywords :   


Myriad Genetics Upgraded by Credit Suisse to "Neutral"

2014-02-09 03:19:34| Biotech - Topix.net

The firm currently has a $29.00 target price on the stock. Credit Suisse's price objective indicates a potential downside of 10.02% from the stock's previous close.

Tags: credit suisse neutral genetics

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Eastern North Pacific Tropical Weather Outlook
28.09Atlantic Tropical Weather Outlook
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Public Advisory Number 5
28.09Summary for Tropical Storm Joyce (AT1/AL112024)
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Forecast Discussion Number 5
28.09Tropical Storm Joyce Wind Speed Probabilities Number 5
More »